We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Almirall and BioFocus Announce Collaboration to Find New Hit Compounds against Key Targets

Targets are related to the treatment of respiratory and inflammatory conditions
News

Midatech receives Regulatory Approval for Clinically Testing Ultra-small Gold Nanoparticles

Midatech Ltd announced it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG.
News

Stage II Colon Cancer Recurrence Signature Published in the Journal of Clinical Oncology

The article entitled “Development and Independent Validation of a Prognostic Assay for Stage II Colon Cancer Using Formalin-Fixed Paraffin-Embedded Tissue” gives detail on the development and validation of a prognostic gene signature in Stage II colon cancer.
News

Starna Scientific Appoints Director

Nathan Hulme has been appointed to help guide the company’s expansion plans.
News

AB SCIEX Acquires Labindia’s Mass Spectrometry Division

The acquisition represents AB SCIEX’s increasing investment in India responding to the growing needs of India’s scientific community.
News

Arrayjet and Fios Genomics Form Strategic Alliance

Arrayjet Ltd and Fios Genomics announce the formation of a strategic alliance that allows both companies to offer a complete, end to end, microarray solution for their customers.
News

Epistem Announces Partnership with The University of Manchester

Partnership will allow Epistem to expand its wound healing models range.
News

MBio Diagnostics Announces Key Journal Publication

Company is developing a diagnostic system that delivers a panel of infectious disease results.
News

License Agreement Between Leica Microsystems, the Max Planck Society and DKFZ

Developing the next Stimulated Emission Depletion microscopy generation.
News

Aquinox Initiates Two Phase IIa Clinical Studies in Airway Inflammation Following Successful Phase I

AQX-1125, a novel oral anti-Inflammatory compound, exhibits desirable properties for continued development.
Advertisement